InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Crinetics Pharmaceuticals, Inc.

CRNX Clue Score54
United States Fiscal year ends December CIK 0001658247 Results filed 3 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

52
Insider
Date
Role
Action
Shares
Price
Amount
Jeff E. Knight
8 Apr 2026
Chief Dev. & Operating Officer
Sold after exercise
85,163
$40.10
$3.42M
Isabel Kalofonos
5 Jan 2026
Chief Commercial Officer
Sold after exercise
2,500
$55.00
$137.50K
Dana Pizzuti
1 Dec 2025
Chief Med and Dev Officer
Sold after exercise
5,000
$45.02
$225.10K
Dana Pizzuti
3 Nov 2025
Chief Med and Dev Officer
Sold after exercise
100
$43.27
$4.33K
Dana Pizzuti
3 Nov 2025
Chief Med and Dev Officer
Sold after exercise
4,900
$42.65
$208.99K
Dana Pizzuti
1 Oct 2025
Chief Med and Dev Officer
Sold after exercise
5,000
$41.81
$209.05K
Matthew K Fust
26 Sep 2025
Director
Sold after exercise
16,000
$44.75
$716.00K
Dana Pizzuti
2 Sep 2025
Chief Med and Dev Officer
Sold after exercise
5,000
$32.10
$160.50K
Dana Pizzuti
22 Aug 2025
Chief Med and Dev Officer
Sold after exercise
30,000
$30.43
$912.90K
Stephen F. Betz
12 Jun 2025
Chief Scientific Officer
Sold after exercise
97,483
$32.23
$3.14M
Dana Pizzuti
3 Feb 2025
Chief Med and Dev Officer
Sold after exercise
5,000
$39.07
$195.35K
Dana Pizzuti
3 Jan 2025
Chief Med and Dev Officer
Sold after exercise
15,000
$52.09
$781.35K
Dana Pizzuti
3 Oct 2024
Chief Med and Dev Officer
Sold after exercise
14,375
$54.63
$785.31K
Marc Wilson
26 Sep 2024
CFO
Sold after exercise
25,000
$51.11
$1.28M
Marc Wilson
25 Jul 2024
CFO
Sold after exercise
19,056
$53.88
$1.03M
Marc Wilson
15 Jul 2024
CFO
Sold after exercise
25,000
$55.00
$1.38M
Jeff E. Knight
15 Jul 2024
Chief Operating Officer
Sold after exercise
27,000
$55.00
$1.49M
James Hassard
5 Jul 2024
Chief Commercial Officer
Sold after exercise
15,000
$44.08
$661.20K
Dana Pizzuti
3 Jul 2024
Chief Med and Dev Officer
Sold after exercise
14,375
$44.87
$645.01K
Marc Wilson
28 Jun 2024
CFO
Sold after exercise
32,129
$43.61
$1.40M
Dana Pizzuti
24 Jun 2024
Chief Med and Dev Officer
Sold after exercise
9,500
$45.73
$434.44K
James Hassard
21 Jun 2024
Chief Commercial Officer
Sold after exercise
15,000
$44.66
$669.90K
Richard Scott Struthers
8 May 2024
President & CEO
Sold after exercise
107,448
$49.40
$5.31M
Dana Pizzuti
15 Apr 2024
Chief Med and Dev Officer
Sold after exercise
14,375
$44.47
$639.26K
Richard Scott Struthers
4 Apr 2024
President & CEO
Sold after exercise
40,951
$49.17
$2.01M
Stephanie Okey
28 Mar 2024
Director
Sold after exercise
17,500
$46.38
$811.65K
Jeff E. Knight
22 Mar 2024
Chief Operating Officer
Sold after exercise
2,359
$45.39
$107.08K
Jeff E. Knight
22 Mar 2024
Chief Operating Officer
Sold after exercise
30,000
$44.22
$1.33M
Matthew K Fust
20 Mar 2024
Director
Sold after exercise
17,500
$45.50
$796.25K
Matthew K Fust
20 Mar 2024
Director
Sold after exercise
17,500
$43.58
$762.65K
Matthew K Fust
20 Mar 2024
Director
Sold after exercise
12,500
$43.57
$544.63K
Matthew K Fust
20 Mar 2024
Director
Sold after exercise
12,500
$43.57
$544.63K
Dana Pizzuti
20 Mar 2024
Chief Med and Dev Officer
Sold after exercise
714
$43.69
$31.19K
Dana Pizzuti
20 Mar 2024
Chief Med and Dev Officer
Sold after exercise
10,000
$43.28
$432.80K
Dana Pizzuti
20 Mar 2024
Chief Med and Dev Officer
Sold after exercise
4,375
$45.89
$200.77K
Dana Pizzuti
3 Jan 2024
Chief Med and Dev Officer
Sold after exercise
14,375
$35.00
$503.13K
Marc Wilson
2 Jan 2024
CFO
Sold after exercise
10,000
$35.47
$354.70K
Dana Pizzuti
21 Dec 2023
Chief Med and Dev Officer
Sold after exercise
9,583
$34.57
$331.28K
Richard Scott Struthers
3 Nov 2023
President & CEO
Sold after exercise
199,082
$30.56
$6.08M
Richard Scott Struthers
2 Nov 2023
President & CEO
Sold after exercise
918
$29.95
$27.49K
Marc Wilson
1 Nov 2023
CFO
Sold after exercise
10,000
$28.75
$287.50K
Alan Seth Krasner
17 Oct 2023
Chief Medical Officer
Sold after exercise
7,000
$30.00
$210.00K
Marc Wilson
20 Jun 2023
CFO
Sold after exercise
20,000
$19.97
$399.40K
Marc Wilson
20 Jun 2023
CFO
Sold after exercise
10,922
$19.96
$218.00K
Matthew K Fust
13 Jul 2022
Director
Sold after exercise
5,700
$20.96
$119.45K
Alan Seth Krasner
19 Jan 2022
Chief Medical Officer
Sold after exercise
6,700
$21.21
$142.08K
Matthew K Fust
1 Nov 2021
Director
Sold after exercise
8,954
$25.50
$228.33K
Matthew K Fust
8 Sep 2021
Director
Sold after exercise
6,046
$25.50
$154.17K
Matthew K Fust
26 Jul 2021
Director
Sold after exercise
5,000
$19.59
$97.95K
Matthew K Fust
19 Jul 2021
Director
Sold after exercise
5,000
$19.50
$97.50K
Matthew K Fust
12 Jul 2021
Director
Sold after exercise
5,000
$20.71
$103.55K
Matthew K Fust
16 Dec 2019
Director
Sold after exercise
3,500
$22.50
$78.75K
Show all 216 transactions →

What was left out

Form 4 filings counted 272
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 20
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 52
Sales at will 86
Transactions with no price 0
Shares from compensation/vesting 22,218,718
Sales filed before the plan box existed 86
History held since 20 Jul 2018